Auto recalls have been very common in the news lately. General Motors had a large recall on its older models, countless automakers have recalls on failed Takata airbags, and now Toyota has issued a recall on 361,800 automobiles worldwide.
About the Toyota Automobile Recall
Toyota Motor Co.’s global recall involves some 361,800 vehicles, including its Camry Sedan, and covers three separate defects.
Of the recalled cars, 170,000 are defective Camrys with a faulty ball joint that could cause the driver to lose control of their vehicle. 120,000 of these Camrys are in Europe, and approximately 40,000 are in Japan.
A second portion of the recall includes 105,800 Hiace, Regius Ace, and Dyna Models, mainly in Japan, for a fuel pape defect. The third part of the recall includes 86,000 Crown and Crown Majesta models in Japan for a seat belt glitch.
Toyota has issued a statement in which it said it was not aware of any crashes, injuries, or deaths resulting from the recalled models.
Share this article:
Among infants born to HIV-infected women, those exposed to the antiretroviral drug atazanavir (Bristol-Myers Squibb) are twice as likely as other infants to be born with a congenital abnormality, according to a new study.
About the Risks Atazanavir Poses to Infants
Medscape reports that among the most common congenital abnormalities resulting from atazanavir are musculoskeletal and skin-related birth defects. However, studies are still being conducted and some say it would be premature to advise against using atazanavir during pregnancy.
Dr. Paige Williams of the Harvard School of Public Health in Boston told Reuters Health that the studies on atazanavir and their results “are very reassuring, and we didn't have any results that suggested that women not receive antiretrovirals during pregnancy…the benefits of using antiretrovirals still far outweigh the risks for HIV-infected women.” However, some have suggested that the first-trimester drug efavirenz exposure might increase birth defect risk.
Study on Antiretroviral Drug Use Risk to Infants
- 2,580 children were enrolled in the Surveillance Monitoring of ART Toxicities (SMARTT) Study of the Pediatric HIV/AIDS Cohort Study network from March 23, 2007 to June 18, 2012.
- SMARTT is a current study at 22 medical centers in the United States.
- 175 children had congenital anomalies, for an occurrence of 6.78%.
- The threat of skin irregularities was five times greater with atazanavir exposure, and the risk of musculoskeletal anomalies was more than doubled.
- The study did not show any correlation between first-trimester exposure to efavirenz and congenital abnormalities.
- Women who take antiretroviral drugs usually take more than one type of drug, which complicates its process and may cause congenital defects among infants.
Share this article:
A Portland man was fatally injured Saturday morning following a head-on collision on FM 136.
About the Portland Collision
Reports indicate Johnson was traveling south in the northbound lanes of FM 136 when the accident occurred. He was killed on impact.
The driver of the pickup was able to escape from the burning vehicle and was transported to Christus Spohn Memorial Hospital for treatment.
Authorities are still investigating the accident.
Texas Auto Accident Statistics
The following information was provided by the Texas Department of Transportation (TxDOT):
- 3,377 people were killed in auto accidents in Texas in 2013.
- Another 232,041 people were injured with 65,539 people suffering serious injuries.
- 55.76-percent of recorded traffic fatalities occurred in rural areas of the state and 523 people were killed in head-on collision.
- Using available crash data for 2013, TxDOT estimates that a person was killed in an auto accident in Texas every 2 hours and 36 minutes and a person was injured every 2 minutes and 16 seconds.
Share this article: